RMTI vs. RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, and RMD
Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), and ResMed (RMD). These companies are all part of the "health care equipment" industry.
Rockwell Medical vs. Its Competitors
Rockwell Medical (NASDAQ:RMTI) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations.
Rockwell Medical has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500.
23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are held by institutional investors. 1.9% of Rockwell Medical shares are held by insiders. Comparatively, 0.0% of ReShape Lifesciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Rockwell Medical currently has a consensus price target of $4.00, indicating a potential upside of 311.61%. Given Rockwell Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Rockwell Medical is more favorable than ReShape Lifesciences.
Rockwell Medical has a net margin of -1.25% compared to ReShape Lifesciences' net margin of -86.36%. Rockwell Medical's return on equity of 8.55% beat ReShape Lifesciences' return on equity.
In the previous week, ReShape Lifesciences had 5 more articles in the media than Rockwell Medical. MarketBeat recorded 6 mentions for ReShape Lifesciences and 1 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 1.87 beat ReShape Lifesciences' score of 0.57 indicating that Rockwell Medical is being referred to more favorably in the media.
Rockwell Medical has higher revenue and earnings than ReShape Lifesciences. Rockwell Medical is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks.
ReShape Lifesciences received 86 more outperform votes than Rockwell Medical when rated by MarketBeat users. Likewise, 66.00% of users gave ReShape Lifesciences an outperform vote while only 57.67% of users gave Rockwell Medical an outperform vote.
Summary
Rockwell Medical beats ReShape Lifesciences on 15 of the 19 factors compared between the two stocks.
Get Rockwell Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Rockwell Medical Competitors List
Related Companies and Tools
This page (NASDAQ:RMTI) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy RMTI Stock Free RMTI Stock Alerts